Tumaini Bundibugyo Ebola Vaccine Trial Starts in Bunia · Chronopin

HealthPosted 09/30/202609/30/2026 at 3:58 am@ThePinGang To timeline

University of Antwerp

10/20/2026 - 06/30/2027ESTIMATED69% CONFIDENCEClinicalTrials.gov^[1] lists a start date of 2026-10-20 flagged "ESTIMATED" with status "NOT_YET_RECRUITING", and study completion of 2027-06 (estimated).

Start: Oct 20, 202650% CONFIDENCEfrom the source
End: Jun 30, 202750% CONFIDENCEfrom the source

Tumaini Bundibugyo Ebola Vaccine Trial Starts in Bunia

The Tumaini Phase 2/3 platform trial plans to vaccinate the contacts of confirmed Bundibugyo cases in rings around each case in Bunia, targeting 3,810 participants. Run by the University of Antwerp and INRB with CEPI and WHO, it is registered to start on 20 October 2026.

References 469% CONFIDENCEOverall confidence: 69%How well the pin's source and references back up its dates.Weighted average of how firmly 4 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins from 50% to 74% confidence

The first entry is always the pin's source. Overall confidence is a weighted average of how firmly each reference supports the start and end times used above; a reference counts half as much for every 180 days older than the newest.

[1]50%
clinicaltrials.gov/study/NCT07842107
clinicaltrials.gov· Posted Sep 30, 2026· Starts Oct 20, 2026 ✓· Ends Jun 30, 2027 ✓· 25% of score
ClinicalTrials.gov lists a start date of 2026-10-20 flagged "ESTIMATED" with status "NOT_YET_RECRUITING", and study completion of 2027-06 (estimated).
[2]75%
New Ebola vaccine trial launches as outbreak spreads in DR Congo (UN News)
news.un.org· Added Sep 30, 2026· 25% of score
[3]75%
Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says (STAT)
statnews.com· Added Sep 30, 2026· 25% of score
[4]75%
Experts convened by WHO advise on candidate treatments and vaccines for Bundibugyo virus (WHO)
who.int· Added Sep 30, 2026· 25% of score

Suggest a correction

Something missing or wrong? Say it in your own words: a link that backs this pin up, a different start or end date and why, or a fact it lacks or gets wrong. The AI checks it against this pin's sources, searches for better ones, and adds any page that backs you up. The pin's own sources still count most. A picture that shows something else, or shows it badly, is looked at too, and moved down or replaced.

Health09/30/2026@ThePinGang
70,000 Ervebo Doses Released for DRC's Bundibugyo Ebola Outbreak
Bunia, Ituri Province, Democratic Republic of the CongoWorld Health Organization
Starts 08/17/2026CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins78% CONFIDENCEOverall confidence: 78%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better45 days agoWHO's^[1] 20 August 2026 release says the ICG informed the DRC government 'on Monday' of the immediate initial release, which is Monday 17 August 2026.
The International Coordinating Group on Vaccine Provision released 70,000 Ervebo doses from the global Ebola stockpile to the DRC: 20,000 for a Phase 3 trial and 50,000 for frontline and health workers. WHO stresses it is not known whether Ervebo protects against Bundibugyo virus.
0.70
Health09/30/2026@ThePinGang
Ebola Bundibugyo Emergency Committee Due to Meet a Third Time
World Health Organization, Avenue Appia 20, 1211 Geneva, SwitzerlandWorld Health Organization
Starts 11/18/2026ESTIMATEDDate confidence: ESTIMATEDA target, not a fixed dateHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all ESTIMATED pins70% CONFIDENCEOverall confidence: 70%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins from 50% to 74% confidencein 48 daysNo date is announced: the committee met for the first time on 22 May and again on "18 August 2026" ("met for the second time to reassess the situation"), and WHO's^{[1][2][3][4][5]} IHR Q&A says Emergency Committees "are reconvened at least every three months", so mid-November is estimated.
WHO's IHR Emergency Committee on the Bundibugyo Ebola epidemic is due to reconvene, roughly three months after its 18 August meeting, to say whether the emergency still stands. WHO counts 7,890 confirmed cases and 3,799 deaths in the DRC as of 23 September 2026.
0.68
Health09/30/2026@ThePinGang
Uganda Declares Its Bundibugyo Ebola Outbreak Over
Kampala, UgandaWorld Health Organization
Starts 08/27/2026CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins78% CONFIDENCEOverall confidence: 78%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better35 days agoWHO^[1] Africa's news release dated 27 August 2026 says the 42-day countdown from the last patient's discharge on 16 July was complete and the outbreak had ended; Uganda had announced interruption of local transmission on 28 July.
Africa CDC and WHO welcomed the end of Uganda's Bundibugyo Ebola outbreak after 42 consecutive days without a new confirmed case, counted from the last imported patient's discharge on 16 July 2026. Uganda reported 20 confirmed cases (15 imported from DRC, 5 local), 18 recoveries and 2 deaths.
0.67
Health09/30/2026@ThePinGang
CPHIA 2026 Public Health in Africa Conference Opens in Addis Ababa
Addis Ababa, EthiopiaAfrica CDC
11/23/2026 - 11/27/2026SCHEDULEDDate confidence: SCHEDULEDGiven as scheduledHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all SCHEDULED pins75% CONFIDENCEOverall confidence: 75%How well the pin's source and references back up its dates.Weighted average of how firmly 4 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or betterin 53 daysAfrica CDC's^[1][2][3] event page gives "23-27 November 2026" in Addis Ababa, co-hosted with the Government of Ethiopia.
Africa CDC and Ethiopia host the 5th International Conference on Public Health in Africa, 23-27 November 2026, under the theme of health security and sovereignty as the Bundibugyo Ebola emergency continues.
0.64
Health09/30/2026@ThePinGang
Bundibugyo Ebola Reaches Sud Ubangi and Dungu, Nearing South Sudan
Dungu, Haut-Uele Province, Democratic Republic of the CongoWorld Health Organization
Starts 09/25/2026CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins78% CONFIDENCEOverall confidence: 78%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better6 days agoThe WHO^[1] Disease Outbreak News item is dated 25 September 2026; its figures run to 23 September.
WHO's 25 September Disease Outbreak News reports the DRC outbreak spread to Bulu (Sud Ubangi, a new province) and Dungu (Haut-Uele, bordering South Sudan), for 63 health zones in seven provinces. As of 23 September the DRC had 7,890 confirmed cases including 3,799 deaths (CFR 48.1%).
0.63
Health09/30/2026@ThePinGang
Uganda Starts Five-Day National Measles-Rubella Vaccination Campaign
Kampala, UgandaUganda Ministry of Health
10/01/2026 - 10/05/2026SCHEDULEDDate confidence: SCHEDULEDGiven as scheduledHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all SCHEDULED pins75% CONFIDENCEOverall confidence: 75%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or betterTodayThe government's campaign notice and The Observer^[2] both give October 1-5, 2026 ("a five-day national measles-rubella vaccination campaign set for October").
Uganda's Ministry of Health runs a nationwide measles-rubella booster campaign from 1 to 5 October 2026 for children under five regardless of past vaccination, aiming for about 7.47 million children after measles outbreaks in 18 districts this year.
0.62
Health09/21/2026@HealthDesk
WHO Declares the West Africa Ebola Outbreak an Emergency
World Health Organization, Avenue Appia 20, 1211 Geneva, SwitzerlandWorld Health Organization
Starts 08/08/2014CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins87% CONFIDENCEOverall confidence: 87%How well the pin's source and references back up its dates.Weighted average of how firmly 2 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better12.1 years agoThe WHO^[2] declared the outbreak a public health emergency of international concern on 8 August 2014, following the emergency committee's meeting of 6-7 August.
Eight months after the first cases in Guinea, the WHO declared the Ebola epidemic in West Africa a public health emergency of international concern. It became the largest Ebola outbreak in history: more than 28,000 cases and 11,000 deaths across Guinea, Liberia and Sierra Leone.
0.61
Health09/30/2026@ThePinGang
Africa CDC-WHO Continental Ebola Plan Reaches Its End Date
Africa CDC Headquarters, Addis Ababa, EthiopiaAfrica CDC
Starts 11/30/2026ESTIMATEDDate confidence: ESTIMATEDA target, not a fixed dateHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all ESTIMATED pins69% CONFIDENCEOverall confidence: 69%How well the pin's source and references back up its dates.Weighted average of how firmly 4 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins from 50% to 74% confidencein 60 daysWHO^[1] describes "The six-month plan, covering June to November 2026", giving only a month, so the pin takes the last day of November.
The six-month joint Africa CDC and WHO continental Ebola preparedness and response plan, which sought US$518 million, covers June to November 2026 and so runs out at the end of November. Africa CDC's advisers still advise keeping the continental emergency in place.
0.61
Health09/20/2026@HealthDesk
MenQuadfi's Phase 3 Trial in Meningococcal Infection Reads Out
SanofiParis, Grand Paris, France
Starts 03/13/2028ESTIMATEDDate confidence: ESTIMATEDA target, not a fixed dateHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all ESTIMATED pins50% CONFIDENCEOverall confidence: 50%How well the pin's source and references back up its dates.Weighted average of how firmly 1 reference, the source included, supports the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins from 50% to 74% confidencein 1.4 yearsClinicalTrials.gov^[1] lists 2028-03-13 as the estimated primary completion date; a sponsor's estimate, and trials of this size routinely slip.
Sanofi's phase 3 trial of MenQuadfi in meningococcal infection reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 4,568 participants. The purpose of this study is to describe the safety and immunogenicity of MenACYW conjugate vaccine compared with locally-licensed meningococcal vaccines in healthy infants and toddlers in China. Study details include: * Study duration (including 6-month safety follow-up after the last dose): * Cohort I (Groups 1 and 2): approximately 211 or 271 days (approximately 7 or 9 months) * Cohort II (Groups 3 and 4): up to 18 months * Cohort III (Groups 5 and 6): up to 21 months * Cohort III (Group 7): approximately 16 months * Vaccination Visits Period: * Cohort I (Groups 1 and 2): a 2-dose vaccination at V01 (D01) and V02 (D31) or V03 (D91). Two blood samples are collected pre-vaccination (D01) and 30 days post the 2nd dose of vaccination (D61 or D121).
0.60
Health09/20/2026@HealthDesk
PCV21 Vaccine's Phase 3 Trial in Pneumococcal Immunization Reads Out
SanofiParis, Grand Paris, France
Starts 06/07/2027ESTIMATEDDate confidence: ESTIMATEDA target, not a fixed dateHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all ESTIMATED pins50% CONFIDENCEOverall confidence: 50%How well the pin's source and references back up its dates.Weighted average of how firmly 1 reference, the source included, supports the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins from 50% to 74% confidencein 249 daysClinicalTrials.gov^[1] lists 2027-06-07 as the estimated primary completion date; a sponsor's estimate, and trials of this size routinely slip.
Sanofi's phase 3 trial of PCV21 Vaccine in pneumococcal immunization reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 2,195 participants. This is a phase 3 randomized, modified double-blind study whose purpose is to measure whether 3 lots of the investigational pneumococcal vaccine PCV21 can help the body to develop germ-fighting agents called "antibodies" (immunogenicity) in a similar way (ie, same immune response) when they are given to infants aged from approximately 2 months (42 to 89 days) and are safe compared to a licensed 20-valent pneumococcal vaccine (20vPCV) (Prevnar 20™). The study duration per participant will be up to approximately 17 months. The study vaccines (either PCV21 or 20vPCV) will be administered at approximately 2, 4, 6 and 12 months of age.
0.60
Health09/30/2026@ThePinGang
Gavi Board Meets December 9-10, 2026 on Vaccine Programmes
Gavi, the Vaccine Alliance, Chemin du Pommier 40, 1218 Le Grand-Saconnex, Geneva, SwitzerlandGavi, the Vaccine Alliance
12/09/2026 - 12/10/2026SCHEDULEDDate confidence: SCHEDULEDGiven as scheduledHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all SCHEDULED pins75% CONFIDENCEOverall confidence: 75%How well the pin's source and references back up its dates.Weighted average of how firmly 4 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or betterin 69 daysGavi's^[1][2][3][4] governance calendar lists 2026 board meetings as "25-26 March", "1-2 July" and "9-10 December"; the meeting location is not stated on the page.
The board of Gavi, the Vaccine Alliance, holds its December 2026 meeting on 9-10 December, the governing body that oversees vaccine programmes for measles, malaria, cholera and other diseases in lower-income countries.
0.59
Transport09/15/2026@BuildDesk
Indonesia Opens the Bakauheni-Terbanggi Besar Toll Road, Trans Sumatera's First Major Stretch
Bakauheni, Lampung Selatan, Lampung, IndonesiaHutama Karya
Starts 03/08/2019CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins90% CONFIDENCEOverall confidence: 90%How well the pin's source and references back up its dates.Weighted average of how firmly 3 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better7.6 years agoHappened as dated, per the source^[1]: President Joko Widodo inaugurated the toll road at the Natar toll gate, with the remaining sections becoming operational on March 8, 2019.
Indonesia opened the 140.9km Bakauheni-Terbanggi Besar toll road in Lampung, the flagship first section of the Trans Sumatera Toll Road network built by state contractor Hutama Karya.
0.59